Tumor-directed cellular immunity in malignant melanoma and its modification by surgical treatment.
作者信息
Cochran A J, Thomas C E, Spilg W G, Grant R M, Cameron-Mowat D E, Mackie R M, Lindop G
出版信息
Yale J Biol Med. 1973 Dec;46(5):650-4.
Abstract
摘要
相似文献
1
Tumor-directed cellular immunity in malignant melanoma and its modification by surgical treatment.恶性黑色素瘤中的肿瘤导向性细胞免疫及其手术治疗的改变
Yale J Biol Med. 1973 Dec;46(5):650-4.
2
Immunologic mechanisms in malignant melanoma of the skin.皮肤恶性黑色素瘤中的免疫机制。
Trans Ophthalmol Soc U K (1962). 1977 Sep;97(3):385-8.
3
The cell-mediated immunity in patients with malignant melanoma.恶性黑色素瘤患者的细胞介导免疫
Neoplasma. 1978;25(3):353-7.
4
Cellular immunity to breast carcinoma and malignant melanoma.对乳腺癌和恶性黑色素瘤的细胞免疫。
Br J Cancer Suppl. 1973 Aug;1:77-82.
5
Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease.恶性疾病患者术后肿瘤导向性细胞介导免疫的抑制
Br Med J. 1972 Oct 14;4(5832):67-70.
6
7
[Immunotherapy].[免疫疗法]
Acta Chir Belg. 1974 Mar;73(2):265-93.
8
Surgery and the management of cutaneous melanoma.皮肤黑色素瘤的外科手术及管理
Br J Surg. 2013 Feb;100(3):313-5. doi: 10.1002/bjs.9054.
9
[Immunology of melanoma].[黑色素瘤的免疫学]
Acta Chir Belg. 1974 Mar;73(2):135-88.
10
[Cellular immunity in patients with melanoma].[黑色素瘤患者的细胞免疫]
Vopr Onkol. 1976;22(12):3-5.
引用本文的文献
1
Immunopotentiation with levamisole in resectable bronchogenic carcinoma: a double-blind controlled trial; Study Group for Bronchogenic Carcinoma.左旋咪唑对可切除支气管源性癌的免疫增强作用：一项双盲对照试验；支气管源性癌研究组
Br Med J. 1975 Aug 23;3(5981):461-4. doi: 10.1136/bmj.3.5981.461.
本文引用的文献
1
ANTIGENIC PROPERTIES OF HUMAN TUMOURS: DELAYED CUTANEOUS HYPERSENSITIVITY REACTIONS.人类肿瘤的抗原特性：迟发型皮肤超敏反应
Br Med J. 1964 Jan 25;1(5377):209-12. doi: 10.1136/bmj.1.5377.209.
2
On concomitant immunity in tumour-bearing hamsters.关于荷瘤仓鼠的伴随免疫
Nature. 1967 Feb 18;213(5077):674-6. doi: 10.1038/213674a0.
3
Factors controlling concomitant immunity in tumor-bearing hamsters: effects of prior splenectomy and tumor removal.携带肿瘤的仓鼠中控制伴随免疫的因素：先前脾切除和肿瘤切除的影响。
J Natl Cancer Inst. 1969 Sep;43(3):533-43.
4
Evolution of cell-mediated immunity in mice bearing an antigenic tumor. Influence of tumor growth and surgical removal.携带抗原性肿瘤小鼠的细胞介导免疫的演变。肿瘤生长和手术切除的影响。
J Natl Cancer Inst. 1969 Jul;43(1):111-21.
5
Indications of cellular immunological reactions against autochthonous tumour in cancer patients studied in vitro.
East Afr Med J. 1968 Jul;45(7):484-97.
6
An in vitro demonstration of cellular immunity against autologous mammary carcinoma in man.人体针对自身乳腺癌细胞免疫的体外实验证明
Acta Med Scand. 1969 Jul-Aug;186(1-2):101-3. doi: 10.1111/j.0954-6820.1969.tb01446.x.
7
Dependence of concomitant tumor immunity on continued antigenic stimulation.伴随肿瘤免疫对持续抗原刺激的依赖性。
J Natl Cancer Inst. 1971 Jun;46(6):1169-75.
8
Preliminary observations on the effect of halothane and oxygen anesthesia on the immunologic response in man.氟烷与氧气麻醉对人体免疫反应影响的初步观察
Anesth Analg. 1970 Sep-Oct;49(5):809-16.
9
The immunological reactivity of patients with cancer: a preliminary report.癌症患者的免疫反应性：初步报告。
Can Med Assoc J. 1968;99(8):342-7.
10
Demonstration of cell-bound and humoral immunity against neuroblastoma cells.针对神经母细胞瘤细胞的细胞免疫和体液免疫的证明。
Proc Natl Acad Sci U S A. 1968 Aug;60(4):1231-8. doi: 10.1073/pnas.60.4.1231.
Zotero 插件